ヒトの血および脳脊髄液におけるラセミックエフロニチンの薬物動態:ヒトのアフリカトライパノソミアシスに対するL-エフロニチンの臨床展望
Mikael Boberg1,2, Kesara Na-Bangchang3, Michael Ashton4
1Unit for Pharmacokinetics and Drug Metabolism, Sahlgrenska Academy, University of Gothenburg, Box 431, 405 30, Gothenburg, Sweden. mikael.boberg@gu.se.
The AAPS journal
|September 4, 2025
まとめ
ヒトのアフリカトライパノソミアシス (HAT) に対して口服用L-エフロニチン治療の開発には,高い頻度の投与が必要である. ニフュルティモックスとの併用療法により,L-エフロニチン投与量を減らすことができます.
科学分野:
- 薬理学について
- 感染症
- 薬物開発
背景:
- 現在進行中のガンビエンスヒトアフリカトライパノソミアシス (g- HAT) の治療は,静脈内投与のエフロニチンで,しばしばニフルティモックスと併用されます.
- エフロニチンの経口投与は,患者の便利性とアクセシビリティのために望ましい.
- エフロニチンは,L-エナチオメアとD-エナチオメア間で,エナチオセレクティブな薬動性を示し,インビトロの効能が異なっています.
研究 の 目的:
- 経口投与後のL-エフロニチンの血および脳脊髄液濃度を予測する.
- g- HATの治療のための治療目標濃度を達成する確率を推定する.
- L-エフローリニチン単独療法と併用療法の潜在的な投与方法を検討する.
主な方法:
- 脳脊髄液におけるL- とD- エフローリニチン濃度を記述するために,薬理学的なコンパートメントモデルを使用した.
- 全体のエフロニチン濃度に関する外部データを用いてモデルを検証した.
- 様々な口服用L-エフロニチン (125~1000 mg/kg/日) を1日数回投与したシミュレーションを行った.
主要な成果:
- 高濃度のL-エフローリニチン (L-eflornithine) を口服する (750 mg/ kg/ 日,4回または1日12回) は,有効な単体療法に必要なと予測されています.
- ニフュルティモックスと併用した口服L-エフロニチン (375 mg/ kg/ 日,4回または12回) の低用量投与は,治療効果のある脳脊髄液濃度を達成することができる.
- シミュレーション結果は,口服用L-エフロニチン投与戦略を最適化するための枠組みを提供します.
結論:
- 末期的なg- HATに対するL- エフロニチン単独療法には,頻繁に高用量投与が必要である.
- ニフュルティモックスとの併用療法により,口服L-エフロニチンの投与頻度が減り,投与量も低くなる可能性があります.
- 提案されている経口L-エフロニチン療法のさらなる臨床評価は,g- HATと戦うために必要である.
関連する概念動画
Antiepileptic Drugs: Potassium Channel Activators
272
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
272
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.1K
Racemic Mixtures and the Resolution of Enantiomers
18.7K
A racemic mixture, or racemate, is an equimolar mixture of enantiomers of a molecule that can be separated using their unique interaction with chiral molecules or media. Racemic mixtures are denoted by the (±)- prefix. This ‘optical rotation descriptor’ applies to the whole solution of a racemic mixture rather than a specific stereoisomer. Enantiomers typically have the same physical and chemical properties. Hence, they are not easily separable. However, enantiomers can exhibit...
18.7K
Time Course of Drug Effect
2.2K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.2K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
123
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
123


